What is a monovalent inactivated rabies vaccine?

A monovalent inactivated rabies vaccine (mRABV) is a type of rabies vaccine that is made using a single strain of the rabies virus. The virus is inactivated, which means that it is no longer able to cause disease. This type of vaccine is typically used to prevent rabies in humans who have been exposed to the virus.

mRABV vaccines are produced by growing the rabies virus in cell culture and then inactivating it with a chemical such as formalin. The inactivated virus is then purified and mixed with an adjuvant, which is a substance that helps to boost the immune response to the vaccine.

mRABV vaccines are very effective at preventing rabies. They are typically given as a series of four or five shots over a period of several weeks. The first shot is given as soon as possible after exposure to the rabies virus, and the subsequent shots are given at regular intervals over the next few weeks.

mRABV vaccines are generally well-tolerated, with the most common side effects being pain at the injection site, headache, and fatigue. Serious side effects are rare.

mRABV vaccines are an essential part of rabies prevention. They are safe and effective, and they can save lives.